Japan, Sept. 7 -- DAMIAN PHARMA AG has got intellectual property rights for 'R-FADROZOLE FOR USE IN TREATMENT OF ALDOSTERONISM.' Other related details are as follows:
Application Number: JP,2024-061501
Category (FI): A61P43/00,105,A61P9/06,A61K9/20,A61P43/00,111,A61K31/437,A61P5/42,A61K31/4184,A61P9/04,A61P13/12,A61P9/12,A61P3/04,A61P9/10
Stage: Grant (IP right granted following substantive examination.)
Filing Date: April 5, 2024
Publication Date: July 30, 2024
The original document can be viewed at: https://www.j-platpat.inpit.go.jp/p0100
Disclaimer: Curated by HT Syndication....